# OnCo record nct05000294 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05000294/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05000294", "NCT05000294" ;
  schema:name "Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types"@en ;
  schema:description "A phase 1/2 trial of atezolizumab and tivozanib in gallbladder cancer, run by University of Florida, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05000294/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05000294> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest", "gallbladder-deep-dive" ;
  onco:phase "1/2" ;
  onco:cancers <https://onco.cc/cancers/gallbladder/>, <https://onco.cc/cancers/cholangiocarcinoma/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/atezolizumab/>, <https://onco.cc/drugs/tivozanib/> .